Be cautious with pork products—including bacon, ham, and sausage.
by Nicolas Hulscher, MPH
Most
Americans assume the “gene-based vaccine era” began with COVID-19. But
few realize that a genetic vaccine platform has been deployed in
food-producing animals for more than a decade—largely outside of public
awareness or mainstream discussion.
In 2012, the USDA licensed Merck’s SEQUIVITY® platform
for use in commercial swine herds. SEQUIVITY is marketed as an “RNA
particle” vaccine system designed to deliver genetic instructions so the
animal’s cells produce targeted antigens. In other words: this is a
gene-based injection platform used in pigs raised for human consumption,
and it has been circulating in the U.S. pork production ecosystem since
the early 2010s.
In a company statement, Merck said:
Millions
of doses of the SEQUIVITY vaccine platform have safely been used by
veterinarians in swine herds for more than ten years since the USDA
first issued the license in 2012. It is also being used in other countries such as Canada, Chile, Mexico, and the Philippines.
This
raises an obvious question: how many consumers would knowingly accept
gene-based vaccine platforms being injected into animals entering the
human food chain—without clear labeling, transparent public discussion,
or informed consent? Probably close to zero.
There are no
independent, long-term safety studies specifically designed to assess
residue/biomolecule persistence in edible tissues, downstream consumer
exposure, multi-generation or chronic outcomes, or robust post-market
adverse event transparency at scale.
RNA particle-ridden pork will NOT Make America Healthy Again. Be cautious with pork products—including bacon, ham, and sausage.
Nicolas Hulscher, MPH
Epidemiologist and Foundation Administrator, McCullough Foundation
Support our mission: mcculloughfnd.org